Since its founding in 2006, Escape Therapeutics has dedicated itself to transforming healthcare through discovery, development, and commercialization of innovative stem cell-based curative therapeutics capable of relieving the suffering of children and adults inflicted with devastating diseases or injuries that are currently inadequately treated and/or incurable.

NOX Technologies, Inc., a subsidiary of Nu Skin Enterprises, Inc., is an American company located in Malvern, PA, that engages in identification and detection of cell surface proteins related to aging. It was acquired by Nu Skin Enterprises, Inc. on December 18, 2012 for $12.50 million.

sigma-tau is one of the most important Italian pharmaceutical groups, with a major presence also on the international stage. For more than half a century the company has been active in promoting the quality of life of man and his health. sigma-tau is present today in the most advanced research sectors, maintaining constant relations with scientific institutions with a world-wide reputation in the development of joint projects and in the implementation of original and innovative research programs. These results are the fruit of substantial, ongoing investment in research in the field of pharmaceutical innovation and stem not only from the efforts made to produce new products but also from the success of the company’s consolidated products. Bearing witness to sigma-tau’s achievements are not only the principles and values that inspire our efforts - innovation, dialogue and transparency, ethics, sustainability - but also the facts that have made sigma-tau a leading company in the research, manufacture and marketing of drugs.

Your B2B Partner for Innovation in Health, Wellbeing, Cosmetics and Life Science Over 20 years of experience in the production and use of Ectoin® and other extremolytes makes bitop a valuable and trustworthy partner for the pharmaceutical, cosmetics, and life science industries.

Alkahest develops therapies derived from blood to treat neurological diseases, with an emphasis on age-related cognitive decline. It collaborates with Barcelona, Spain-based Grifols, a global healthcare company producer of plasma therapies. The company’s breakthrough research has demonstrated that factors in the blood plasma of young mice are able to reverse brain deficits in normal aging and Alzheimer’s disease models in mice. The company was founded in 2014 and is based in San Carlos, California.

Renaissance Herbs, Inc., a subsidiary of Avesthagen Ltd., is a company headquartered in Chatsworth, CA, that manufactures botanical health care products. Avesthagen Ltd. acquired Renaissance Herbs, Inc. on July 31, 2007.

Rigel Pharmaceuticals, Inc. operates as a clinical stage biotechnology company. It discovers and develops novel, targeted drugs in the therapeutic areas of immunology, oncology and immune oncology. The firm focuses on intracellular signalling pathways and related targets that are critical to disease mechanisms. The company's products include Tavalisse, Fostamatinib and R835. Rigel Pharmaceuticals was founded by Donald G. Payan, James M. Gower, Thomas A. Raffin, Garry P. Nolan and Ronald B. Garren on June 14, 1996 and is headquartered in South San Francisco, CA.

Beijing Molik Technology Co., Ltd., established on 2003-04-16, Business scope includes technology development,Technology Promotion,technology transfer,technical consulting,Technical Services;Computer System Services;computer repair;selling computers,Software and Auxiliary Equipment,electronic product,Equipment,communication equipment.(Except for projects without administrative permission)(Enterprises independently choose operating projects according to law,Carry out business activities;Items subject to approval by law,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the city's industrial policies.)

BioElectron Technology Corp. is a clinical-stage biotechnology company, which engages in the research and development of therapeutics for inherited mitochondrial disease. The company was founded in 2005 and is headquartered in Mountain View, CA.

Lotus Tissue Repair, Inc. develops dermatologic treatment technologies. Its solutions include a protein replacement therapy for the treatment of dystrophic epidermolysis bullosa, a group of genetic skin disease. The company was founded by Mei Chen, Mark P. de Souza, Philip R. Reilly, David Woodley and James W. Fordyce in 2011 and is headquartered in Lexington, MA.

Korea Research Institute of Bioscience and Biotechnology (KRIBB) is a government research institute in Daejeon, South Korea. It is dedicated to biotechnology research across a broad span of expertise, from basic studies for the fundamental understanding of life phenomena to applied studies such as drug discovery, novel biomaterials, integrated biotechnology and bioinformation.

Takeda Pharmaceutical Company Ltd (武田薬品工業株式会社 Takeda Yakuhin Kōgyō Kabushiki-gaisha) is the largest pharmaceutical company in Asia and one of the top 20 largest pharmaceutical companies in the world by revenue (top 10 following merger with Shire). The company has over 30,000 employees worldwide and achieved 16.2 billion USD in revenue during the 2012 fiscal year. The company is focused on metabolic disorders, gastroenterology, neurology, inflammation, as well as oncology through its independent subsidiary, Takeda Oncology. Its headquarters is located in Chuo-ku, Osaka, and it has an office in Nihonbashi, Chuo, Tokyo. In January 2012, Fortune Magazine ranked the Takeda Oncology Company as one of the 100 best companies to work for in the United States.

Beijing Jiulong Pharmaceutical Co., Ltd., established on 1988-04-13, The business scope includes the manufacture of oral liquid,Granules,capsule,Health products,Pills,Granules,tablet;sell food;Operate the self-produced products and technology export business of the enterprise and its member enterprises;Raw and auxiliary materials required for the production of the enterprise and member enterprises,Instrumentation,Equipment,Import business of spare parts and technology(The state restricts the operation of the company and the state prohibits the import and export of goods except);Operation of imported materials processing and three to one compensation business;Acting as an export agent to transfer self-developed technology to other companies to produce non-self-produced products;technical consulting.(Enterprises independently choose operating projects according to law,Carry out business activities;Sale of food and items subject to approval by law,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the city's industrial policies.)

Bristol-Myers Squibb Company, through its subsidiaries, engages in the discovery, development, licensing, manufacturing, marketing, distribution, and sale of pharmaceuticals and nutritional products. The company operates in two segments, Pharmaceuticals, and Nutritionals. The Nutritionals segment is operated through the company's subsidiary Mead Johnson Nutrition Company (Mead Johnson). The Pharmaceuticals segment is made up of the global pharmaceutical and international consumer medicines business.

The University of California is the nation's best public university system, delivering top-notch research and innovation to California (and the world).